JAC-Antimicrobial Resistance · 2023 · 18 citations · 34 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceAntimicrobial Resistance EpidemiologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance EvolutionCarbapenem ResistanceMolecular Epidemiology Of ResistanceResistance EpidemiologyCarbapenem AntibioticsCarbapenem Resistance MechanismsGenotypic AdaptationGenotypic IdentificationMolecular Epidemiology PhylogeneticsPhylogenetic Analysis Of Resistant IsolatesPhylogenetic Character AnalysisPseudomonas Aeruginosa Resistance
Objectives: (CR-PA) is an ongoing concern. However, information on the evolving antimicrobial resistance profile and molecular epidemiology of CR-PA over time is scarce. Thus, we conducted a cross-sectional analysis to investigate the phenotypic and genotypic characteristics of CR-PA recovered over different time periods, focusing on the isolates exhibiting a ceftolozane/tazobactam resistance phenotype. Methods: A total of 169 CR-PA isolated from clinical specimens at a single centre in Houston, TX, USA were studied. Among them, 61 isolates collected between 1999 and 2005 were defined as historical strains, and 108 collected between 2017 and 2018 were defined as contemporary strains. Antimicrobial susceptibilities against selected β-lactams was determined. WGS data were used for the identification of antimicrobial resistance determinants and phylogenetic analysis. Results: Non-susceptibility to ceftolozane/tazobactam and ceftazidime/avibactam increased from 2% (1/59) to 17% (18/108) and from 7% (4/59) to 17% (18/108) from the historical to the contemporary collection, respectively. Carbapenemase genes, which were not identified in the historical collection, were harboured by 4.6% (5/108) of the contemporary strains, and the prevalence of ESBL genes also increased from 3.3% (2/61) to 16% (17/108). Genes encoding acquired β-lactamases were largely confined to the high-risk clones. Among ceftolozane/tazobactam-resistant isolates, non-susceptibility to ceftazidime/avibactam, imipenem/relebactam and cefiderocol was observed in 94% (15/16), 56% (9/16) and 12.5% (2/16), respectively. Resistance to ceftolozane/tazobactam and imipenem/relebactam was primarily associated with the presence of exogenous β-lactamases. Conclusions: .
34
MUSCLE: multiple sequence alignment with high accuracy and high throughput
R. C. Edgar · Nucleic Acids Research · 2004 · 46.5K citations · Full text
BLAST+: architecture and applications
Christiam Camacho, George Coulouris, Vahram Avagyan et al. · BMC Bioinformatics · 2009 · 23.2K citations · Full text
NCBI prokaryotic genome annotation pipeline
Tatiana Tatusova, Michael DiCuccio, Azat Badretdin et al. · Nucleic Acids Research · 2016 · 7K citations · Full text